Manager × security

GRACE & WHITE INC /NY WST holdings history

Who else holds this security? →

WEST PHARMACEUTICAL SERVICES · CUSIP 955306105 · CIK 903064

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, GRACE & WHITE INC /NY reported 43.53K WST (shares), valued at $15.63M, or 2.47% of its reported non-derivative portfolio. Filed 2026-07-17.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
2.47%
Shares
43.53K
43,530
Reported value
$15.63M
USD

Shares unchanged; reported value increased 43.23%, and weight changed +0.54 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20262.47%43,530SEC filing ↗Filed Jul 17, 2026
Q1 20261.93%43,530SEC filing ↗Filed Apr 21, 2026
Q4 20252.14%43,530SEC filing ↗Filed Jan 26, 2026
Q3 20252.12%45,730SEC filing ↗Filed Oct 23, 2025
Q2 20251.83%45,730SEC filing ↗Filed Jul 24, 2025
Q1 20251.77%41,330SEC filing ↗Filed Apr 22, 2025
Q4 20242.53%41,330SEC filing ↗Filed Jan 29, 2025
Q3 20242.24%41,330SEC filing ↗Filed Oct 21, 2024
Q2 20242.67%43,210SEC filing ↗Filed Jul 22, 2024
Q1 20243.08%43,210SEC filing ↗Filed Apr 25, 2024
Q4 20232.71%43,810SEC filing ↗Filed Feb 1, 2024
Q3 20233.09%44,210SEC filing ↗Filed Oct 25, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20233.09%44,210$16.59MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Oct 25, 2023
Q4 20232.71%43,810$15.43MShares decreased 0.90%; reported value decreased 7.00%, and weight changed -0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 1, 2024
Q1 20243.08%43,210$17.10MShares decreased 1.37%; reported value increased 10.84%, and weight changed +0.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 25, 2024
Q2 20242.67%43,210$14.23MShares unchanged; reported value decreased 16.76%, and weight changed -0.41 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 22, 2024
Q3 20242.24%41,330$12.41MShares decreased 4.35%; reported value decreased 12.84%, and weight changed -0.43 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 21, 2024
Q4 20242.53%41,330$13.54MShares unchanged; reported value increased 9.13%, and weight changed +0.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 29, 2025
Q1 20251.77%41,330$9.25MShares unchanged; reported value decreased 31.65%, and weight changed -0.76 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 22, 2025
Q2 20251.83%45,730$10.01MShares increased 10.65%; reported value increased 8.14%, and weight changed +0.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 24, 2025
Q3 20252.12%45,730$12.00MShares unchanged; reported value increased 19.89%, and weight changed +0.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 23, 2025
Q4 20252.14%43,530$11.98MShares decreased 4.81%; reported value decreased 0.16%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 26, 2026
Q1 20261.93%43,530$10.91MShares unchanged; reported value decreased 8.90%, and weight changed -0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 21, 2026
Q2 20262.47%43,530$15.63MShares unchanged; reported value increased 43.23%, and weight changed +0.54 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 17, 2026
GRACE & WHITE INC /NY · WEST PHARMACEUTICAL SERVICES

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"903064","quarter":"2026Q2","cusip":"955306105"}

get_institutional_manager_history
{"cik":"903064","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.